0001564590-21-040889 | 10-Q | XBRL Viewer

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2021	Aug. 04, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Trading Symbol	VTVT
Entity Registrant Name	vTv Therapeutics Inc.
Entity Central Index Key	0001641489
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity File Number	001-37524
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-3916571
Entity Address, Address Line One	3980 Premier Dr, Suite 310
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Address, Postal Zip Code	27265
Entity Address, City or Town	High Point
Entity Address, State or Province	NC
Entity Small Business	true
Entity Emerging Growth Company	false
Title of 12(b) Security	Class A common stock, par value $0.01 per share
Security Exchange Name	NASDAQ
City Area Code	336
Local Phone Number	841-0300
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		23,093,860

Label	Element	Value
Stock Issued During Period Value Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty	$ 6,000
Stock Issued During Period Value Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty	994,000
Stock Issued During Period Value Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty	1,000,000
Stock Issued During Period Value Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty	44,000
Stock Issued During Period Value Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty	6,956,000
Stock Issued During Period Value Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty	7,000,000
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	0
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	0
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	0
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	0
Aggregate Offering Price	vtvt_AggregateOfferingPrice	5,500,000
Aggregate Offering Price	vtvt_AggregateOfferingPrice	50,000,000.0
Aggregate Offering Price	vtvt_AggregateOfferingPrice	$ 47,000,000.0
Stock Issued During Period Shares Vesting Of Restricted Stock Units	vtvt_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits	11,667
Potential Milestone Payment	vtvt_PotentialMilestonePayment	$ 9,000,000.0
Potential Milestone Payment	vtvt_PotentialMilestonePayment	50,500,000
Potential Milestone Payment	vtvt_PotentialMilestonePayment	115,000,000.0
Potential Milestone Payment	vtvt_PotentialMilestonePayment	$ 75,000,000.0
Period Used To Determine Exchange Value Based On Weighted Average Price Of Class Common Stock	vtvt_PeriodUsedToDetermineExchangeValueBasedOnWeightedAveragePriceOfClassCommonStock	20 days
Common Stock And Preferred Stock Shares Authorized	vtvt_CommonStockAndPreferredStockSharesAuthorized	250,000,000
Common Stock And Preferred Stock Shares Authorized	vtvt_CommonStockAndPreferredStockSharesAuthorized	350,000,000
Maximum Sponsoring Contribution Amount	vtvt_MaximumSponsoringContributionAmount	$ 3,000,000.0
Redeemable Noncontrolling Interest Temporary Equity Redemption Value	vtvt_RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue	60,200,000
Redeemable Noncontrolling Interest Temporary Equity Redemption Value	vtvt_RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue	$ 83,900,000
Number Of Customers	vtvt_NumberOfCustomers	1
Number Of Customers	vtvt_NumberOfCustomers	1
Increase In Common Stock Shares Authorized	vtvt_IncreaseInCommonStockSharesAuthorized	100,000,000
Other Income Expenses Related Party	vtvt_OtherIncomeExpensesRelatedParty	$ 931,000
Other Income Expenses Related Party	vtvt_OtherIncomeExpensesRelatedParty	(565,000)
Other Income Expenses Related Party	vtvt_OtherIncomeExpensesRelatedParty	(717,000)
Other Income Expenses Related Party	vtvt_OtherIncomeExpensesRelatedParty	$ (928,000)
Issuance Of Class A Common Stock Under A T M Offering Shares	vtvt_IssuanceOfClassACommonStockUnderATMOfferingShares	2,180,337
Issuance Of Class A Common Stock Under A T M Offering Shares	vtvt_IssuanceOfClassACommonStockUnderATMOfferingShares	2,638,306
Issuance Of Class A Common Stock Under A T M Offering Shares	vtvt_IssuanceOfClassACommonStockUnderATMOfferingShares	2,180,337
Issuance Of Class A Common Stock Under A T M Offering Shares	vtvt_IssuanceOfClassACommonStockUnderATMOfferingShares	2,638,306
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	$ 22,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	5,313,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	5,335,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	26,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	7,254,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	7,280,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	22,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	5,313,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	5,335,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	26,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	7,254,000
Issuance Of Class A Common Stock Under A T M Offering	vtvt_IssuanceOfClassACommonStockUnderATMOffering	7,280,000
Operating Leases Imputed Interest	vtvt_OperatingLeasesImputedInterest	$ 199,000
Stock Issued During Period Shares Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesRelatedParty	625,000
Stock Issued During Period Shares Conversion Of Convertible Securities Related Party	vtvt_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesRelatedParty	4,375,000
Letter Agreements Expiration Date	vtvt_LetterAgreementsExpirationDate	Dec. 23, 2020
Tax Receivable Agreement Description	vtvt_TaxReceivableAgreementDescription	The Company and MacAndrews are party to a tax receivable agreement (the “Tax Receivable Agreement”), which provides for the payment by the Company to M&F TTP Holdings Two LLC (“M&F”), as successor in interest to vTv Therapeutics Holdings, LLC (“vTv Therapeutics Holdings”), and M&F TTP Holdings LLC (or certain of its transferees or other assignees) of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that the Company actually realizes (or, in some circumstances, the Company is deemed to realize) as a result of (a) the exchange of Class B Common Stock, together with the corresponding number of vTv Units, for shares of the Company’s Class A Common Stock (or for cash), (b) tax benefits related to imputed interest deemed to be paid by the Company as a result of the Tax Receivable Agreement and (c) certain tax benefits attributable to payments under the Tax Receivable Agreement.
Class Of Warrant Or Right Warrants Expiration Date	vtvt_ClassOfWarrantOrRightWarrantsExpirationDate	Dec. 23, 2026
Change In Fair Value Of Warrants Related Party	vtvt_ChangeInFairValueOfWarrantsRelatedParty	$ 717,000
Change In Fair Value Of Warrants Related Party	vtvt_ChangeInFairValueOfWarrantsRelatedParty	928,000
Net Income Loss Available To Common Stockholders Basic And Diluted	vtvt_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	(608,000)
Net Income Loss Available To Common Stockholders Basic And Diluted	vtvt_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	(3,368,000)
Net Income Loss Available To Common Stockholders Basic And Diluted	vtvt_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	(4,849,000)
Net Income Loss Available To Common Stockholders Basic And Diluted	vtvt_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	$ (8,092,000)
Issuance Of Class A Common Stock Under L P C Agreement Shares	vtvt_IssuanceOfClassACommonStockUnderLPCAgreementShares	441,726
Issuance Of Class A Common Stock Under L P C Agreement Shares	vtvt_IssuanceOfClassACommonStockUnderLPCAgreementShares	3,941,726
Issuance Of Class A Common Stock Under L P C Agreement	vtvt_IssuanceOfClassACommonStockUnderLPCAgreement	$ 4,000
Issuance Of Class A Common Stock Under L P C Agreement	vtvt_IssuanceOfClassACommonStockUnderLPCAgreement	1,045,000
Issuance Of Class A Common Stock Under L P C Agreement	vtvt_IssuanceOfClassACommonStockUnderLPCAgreement	1,049,000
Issuance Of Class A Common Stock Under L P C Agreement	vtvt_IssuanceOfClassACommonStockUnderLPCAgreement	39,000
Issuance Of Class A Common Stock Under L P C Agreement	vtvt_IssuanceOfClassACommonStockUnderLPCAgreement	9,048,000
Issuance Of Class A Common Stock Under L P C Agreement	vtvt_IssuanceOfClassACommonStockUnderLPCAgreement	$ 9,087,000
Class Of Warrant Or Right Number Of Shares Issued For Warrants Or Rights	vtvt_ClassOfWarrantOrRightNumberOfSharesIssuedForWarrantsOrRights	6,250,000
Redeemable Non Controlling Interest Exchange Agreement Stock Conversion Ratio	vtvt_RedeemableNonControllingInterestExchangeAgreementStockConversionRatio	1.00
Redeemable Non Controlling Interest Exchange Agreement Stock Conversion Ratio	vtvt_RedeemableNonControllingInterestExchangeAgreementStockConversionRatio	1
Proceeds From Issuance Of Common Stock To Related Party	vtvt_ProceedsFromIssuanceOfCommonStockToRelatedParty	$ 7,000,000
Anteris Bio Inc [Member]
License Fee Received	vtvt_LicenseFeeReceived	2,000,000.0
License Fee Received	vtvt_LicenseFeeReceived	2,000,000.0
Potential Development And Regulatory Milestone Payments Receivable	vtvt_PotentialDevelopmentAndRegulatoryMilestonePaymentsReceivable	151,000,000.0
Ownership Interest Received From License Value	vtvt_OwnershipInterestReceivedFromLicenseValue	4,200,000
J D R F International [Member]
Maximum Research Funding Receivable Based On Achievement Of Research And Development Milestones	vtvt_MaximumResearchFundingReceivableBasedOnAchievementOfResearchAndDevelopmentMilestones	3,400,000
Funding Received	vtvt_FundingReceived	3,300,000
Reneo Pharmaceuticals Inc [Member]
Equity Investments With Readily Determinable Fair Value	vtvt_EquityInvestmentsWithReadilyDeterminableFairValue	5,378,000
Hangzhou Zhongmei Huadong Pharmaceutical Company Limited [Member]
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	1,000,000.0
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	0
Adjustments To Transaction Price For Performance Obligations	vtvt_AdjustmentsToTransactionPriceForPerformanceObligations	0
Maximum Sponsoring Contribution Amount	vtvt_MaximumSponsoringContributionAmount	$ 3,000,000.0

Description of Business, Basis of Presentation and Going Concern - Additional Information (Detail) $ in Millions	6 Months Ended
	Jun. 30, 2021 USD ($)
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Remaining available stock value	$ 50.0

Print Document View Excel Document
Cover Document and Entity Information Notes Details Description of Business, Basis of Presentation and Going Concern - Additional Information (Detail) Uncategorized Uncategorized Items - vtvt-10q_20210630_htm.xml All Reports